Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus
Key Points
The aim is to evaluate the impact of pharmacist-led management on the effectiveness of GLP-1 and GIP/GLP-1 receptor agonists in controlling blood sugar levels.
Comparison of pharmacist-led management versus usual care
Assessment of HbA1c levels
Focus on patients with type 2 diabetes
Pharmacist-led management resulted in a greater reduction in HbA1c levels compared to usual care
Demonstrated improvement in blood sugar control
Abstract
Pharmacist-led management of GLP-1 RA or GIP/GLP-1 RA therapy resulted in a greater improvement in HbA1c when compared to usual care.